PUMA BIOTECHNOLOGY, INC. (PBYI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.16M2012: -$74.45M2013: -$54.83M2014: -$142.28M2015: -$240.28M2016: -$276.60M2017: -$292.39M2018: -$94.66M2019: -$39.05M2020: -$30.40M2021: $1.29M2022: $23.72M2023: $32.64M2024: $30.97M2025: $37.30M$37.30M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$37.30M+20.5%
2024$30.97M-5.1%
2023$32.64M+37.6%
2022$23.72M+1738.8%
2021$1.29M+104.2%
2020-$30.40M+22.1%
2019-$39.05M+58.8%
2018-$94.66M+67.6%
2017-$292.39M-5.7%
2016-$276.60M-15.1%
2015-$240.28M-68.9%
2014-$142.28M-159.5%
2013-$54.83M+26.3%
2012-$74.45M-633.0%
2011-$10.16M